Stock Updates

How has Becton, Dickinson and Company:(NYSE:BDX) performed recently?

Becton, Dickinson and Company (NYSE: BDX) is a large market cap stock with a market cap of 37595.62. It is in the Medical Instruments & Supplies industry and sector Healthcare, with a current P/E of 46.97, a forward P/E of 18.56 and EPS of 3.75. At a stock price of 176.3 (0.19%) it has a dividend yield of 1.50%.

EPS growth for the last five years have been -6.30%, more recently this last year it has grown by -44.10%. The next year growth is going to be about 10.65% and more long-term 13.34% after five years. EPS growth quarter over quarter is 44.50%. Sales growth for the past five years have been 7.60% and sales growth quarter over quarter is 49.50%.

For performance, Becton, Dickinson and Company the past week has seen a gain of 0.63%. For the last month performance for Becton, Dickinson and Company is 7.24%. While the last quarter is 9.09% and half year, 24.71%. Finally for the year, performance is 17.76%.

The 52-week high for Becton, Dickinson and Company, is at -0.68%, and for the 52-week low it comes to a value of 38.55%. The 20-day simple moving average is 3.72% and 14.33% for the 200-day simple moving average.

Volatility for the week is at 1.42%, and for the month it is 1.25%. Becton, Dickinson and Company, has a target price of 182.

In terms of debt, long term debt/equity is 1.42, and for total debt/equity Becton, Dickinson and Company has 1.63. The gross margin is 44.90%, while operating margin is 10.20%, the profit margin is 6.60%. The current ratio is 1.5 and the quick ratio is 1.1.

Insider ownership is at 0.20%, with instituitional ownership at 84.50%. Becton, Dickinson and Company has a payout ratio of 65.80%. With the total shares outstanding coming to 213.66. The shares float is 211.53, with the float short at 1.34%, with short ratio coming to 3.08.

In terms of returns, the return on assets see Becton, Dickinson and Company, get 3.10%, with its returns on investment at 5.20%. Return on equity is 11.10%. So will the investors see the target price of 182, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment